Abstract
The P3J-HR-1 (HR-1) line contains unique Epstein–Barr viruses (EBVs) which fail to immortalize lymphocytes or to induce lymphomas1–4. Virus from Jijoye, the parent of the HR-1 clone, retains lymphocyte-immortalizing ability5,6. Because the HR-1 virus population is a mixture, it has not been possible to identify conclusively the genomic alterations responsible for the nontransforming phenotype7. Submolar fragments produced by restriction enzyme digestion and the variety of patterns found after partial denaturation are evidence for heterogeneity in HR-1 virion DNA8,9. To determine whether every cell carried this virus mixture, or whether the line consisted of cells carrying different variants, we separated the mixture by cell subcloning into new variants, which are found to be distinct from parental HR-1 virus both biologically and in genome structure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miller, G., Robinson, J., Heston, L. & Lipman, M. Proc. natn. Acad. Sci. U.S.A. 71, 4006–4010 (1974).
Menezes, J., Leibold, W. & Klein, G. Expl Cell Res. 92, 478–484 (1975).
Frank, A., Andiman, W. & Miller, G. in Advances in Cancer Research (eds Klein, G. & Weinhouse, S.) 171–210 (Academic, New York, 1976).
Hinuma, Y. et al. J. Virol. 1, 1045–1051 (1967).
Sairenji, T. & Hinuma, Y. Int. J. Cancer 26, 337–342 (1980).
Ragona, G., Ernberg, I. & Klein, G. Virology 101, 553–557 (1980).
Fresen, K. O., Merkt, B., Bornkamm, G. W. & zur Hausen, H. Int. J. Cancer 19, 317–323 (1977).
Sugden, B., Summers, W. C. & Klein, G. J. Virol. 18, 765–775 (1976).
Delius, H. & Bornkamm, G. W. J. Virol. 27, 81–89 (1978).
Yamamoto, N. & Hinuma, Y. Int. J. Cancer 17, 191–196 (1976).
Sugden, B. & Mark, W. J. Virol. 23, 503–508 (1977).
Brandsma, J. & Miller, G. Proc. natn. Acad. Sci. U.S.A. 77, 6851–6855 (1980).
zur Hausen, H., O'Neill, F. J., Freese, U. K. & Hecher, E. Nature 272, 373–375 (1978).
Wilson, G. & Miller, G. Virology 95, 351–358 (1979).
Henle, W. et al. Science 169, 188–190 (1970).
Fischer, D. K. et al. Cell 24, 543–553 (1981).
Dambaugh, T. et al. Proc. natn. Acad. Sci. U.S.A. 77, 2999–3003 (1980).
Skare, J. & Strominger, J. L. Proc. natn. Acad. Sci. U.S.A. 77, 3860–3864 (1980).
Rymo, L., Lindahl, T. & Adams, A. Proc. natn. Acad. Sci. U.S.A. 76, 2794–2798 (1979).
Heller, M., Dambaugh, T. & Kieff, E. J. Virol. 38, 632–648 (1981).
Bornkamm, G. W., Delius, H., Zimber, U., Hudewentz, J. & Epstein, M. A. J. Virol. 35, 603–618 (1980).
Raab-Traub, N., Dambaugh, T. & Kieff, E. Cell 22, 257–269 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heston, L., Rabson, M., Brown, N. et al. New Epstein–Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295, 160–163 (1982). https://doi.org/10.1038/295160a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/295160a0
This article is cited by
-
Transcriptional Regulation of the BCL-6 Gene: Mechanistic Dissection Using Mutant Cell Lines
Molecular Medicine (2002)
-
Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein–Barr virus
Nature Medicine (1995)
-
Epstein–Barr virus infection and replication in a human epithelial cell system
Nature (1992)
-
Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines
Experientia (1991)
-
Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
Nature (1989)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
